News | February 02, 2022
Windlas Biotech concludes SAHPRA audit with an all-clear sign
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
He has over 22 years of experience in pharmaceutical sales & business development
The product will be commercialized from Unichem's Ghaziabad plant
The order strengthens the company’s position in the East African market
It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
The GMP certificate is valid for three years until April 2024.
The company had filed a suit in the High Court of Justice, Ghana
Subscribe To Our Newsletter & Stay Updated
